F5 to Participate in Morgan Stanley Technology, Media and Telecom Conference
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
- Credit Suisse (CS) Falls 6% on 'Unacceptable Loss' as Exposure to Archegos Grew to More Than $20 Billion, Set to Raise Over $2 Billion to Support Liquidity
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SEATTLE--(BUSINESS WIRE)-- F5 Networks, Inc. (NASDAQ: FFIV) today announced that it will participate in Morgan Stanley’s Technology, Media and Telecom Conference, to be conducted virtually.
F5’s presentation, beginning at 3:30 p.m. ET on Tuesday, March 2, 2021, will be webcast live. Interested attendees can access the live webcast via the Investor Relations section of f5.com or via this link. An archived version of the webcast will be available on F5’s Investor Relations page.
F5 (NASDAQ: FFIV) is a multi-cloud application security and delivery company that enables our customers—which include the world’s largest enterprises, financial institutions, service providers, and governments—to bring extraordinary digital experiences to life. For more information, go to f5.com. You can also follow @F5 on Twitter or visit us on LinkedIn and Facebook for more information about F5, its partners, and technologies.
F5 is a trademark, service mark, or tradename of F5 Networks, Inc., in the U.S. and other countries. All other product and company names herein may be trademarks of their respective owners.
SOURCE: F5 Networks
Source: F5 Networks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Air Liquide: First Quarter 2021: Return to Growth for All Activities in an Improving Environment
- Wereldhave Trading Update Q1 2021
- Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Related EntitiesMorgan Stanley, Twitter
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!